Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
. 1980 Jun;41(6):918–922. doi: 10.1038/bjc.1980.169

Treatments affecting the rate of asbestos-induced mesotheliomas.

J C Wagner, R J Hill, G Berry, M M Wagner
PMCID: PMC2010342  PMID: 6252922

Abstract

256 Wistar rats received a single injection into the right pleural cavity of UICC crocidolite in order to induce mesotheliomas. They were then given right intrapleural injectons of BCG, crystalline silica, talc, carrageenan or saline (as a control). There was no significant change in the mesothelioma rate in the rats exposed to BCG, silica or talc, but there was a 3-fold increase in mesothelioma incidence in the group injected with carrageenan.

Full text

PDF
918

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allison A. C., Harington J. S., Birbeck M. An examination of the cytotoxic effects of silica on macrophages. J Exp Med. 1966 Aug 1;124(2):141–154. doi: 10.1084/jem.124.2.141. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Evans R., Alexander P. Mechanism of immunologically specific killing of tumour cells by macrophages. Nature. 1972 Mar 24;236(5343):168–170. doi: 10.1038/236168a0. [DOI] [PubMed] [Google Scholar]
  3. Keller R. Promotion of tumor growth in vivo by antimacrophage agents. J Natl Cancer Inst. 1976 Dec;57(6):1355–1361. doi: 10.1093/jnci/57.6.1355. [DOI] [PubMed] [Google Scholar]
  4. O'Rourke E. J., Halstead S. B., Allison A. C., Platts-Mills T. A. Specific lethality of silica for human peripheral blood mononuclear phagocytes, in vitro. J Immunol Methods. 1978;19(2-3):137–151. doi: 10.1016/0022-1759(78)90174-6. [DOI] [PubMed] [Google Scholar]
  5. Schwartz H. J., Catanzaro P. J. The differential suppression of antigen, lymphokine and mitogen-induced delayed hypersensitivity-type skin reactions by carrageenan. Int Arch Allergy Appl Immunol. 1973;44(3):409–421. doi: 10.1159/000230948. [DOI] [PubMed] [Google Scholar]
  6. Simon L., Jones T. L. Re-evaluation of carrageenan cytotoxicity for macrophages. J Reticuloendothel Soc. 1979 Feb;25(2):133–138. [PubMed] [Google Scholar]
  7. Thomson A. W., Wilson A. R., Cruickshank W. J., Horne C. H. Evaluation of carrageenan as an immunosuppressive agent and mediator of intravascular coagulation. Biomedicine. 1976 May;24(2):102–106. [PubMed] [Google Scholar]
  8. Timbrell V., Gibson J. C., Webster I. UICC standard reference samples of asbestos. Int J Cancer. 1968 May 15;3(3):406–408. doi: 10.1002/ijc.2910030312. [DOI] [PubMed] [Google Scholar]
  9. Wagner J. C., Berry G. Mesotheliomas in rats following inoculation with asbestos. Br J Cancer. 1969 Sep;23(3):567–581. doi: 10.1038/bjc.1969.70. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Wagner J. C., Berry G., Timbrell V. Mesotheliomata in rats after inoculation with asbestos and other materials. Br J Cancer. 1973 Aug;28(2):173–185. doi: 10.1038/bjc.1973.134. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Wagner M. F., Wagner J. C. Lymphomas in the Wistar rat after intrapleural inoculation of silica. J Natl Cancer Inst. 1972 Jul;49(1):81–91. [PubMed] [Google Scholar]
  12. Wagner M. M. Thymectomy and asbestos-induced mesotheliomas in rats. Br J Cancer. 1979 Mar;39(3):337–341. doi: 10.1038/bjc.1979.58. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Yung Y. P., Cudkowicz G. Abrogation of resistance to foreign bone marrow grafts by carrageenans. II. Studies with the anti-macrophage agents iota, kappa, and lambda-carrageenans. J Immunol. 1977 Oct;119(4):1310–1315. [PubMed] [Google Scholar]
  14. Yung Y. P., Cudkowicz G. Suppression of cytotoxic T lymphocytes by carrageenan-activated macrophage-like cells. J Immunol. 1978 Nov;121(5):1990–1997. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES